Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Myeloid Therapeutics to Participate at Investor Conferences in June 2022 | ||
By: PR Newswire Association LLC. - 24 May 2022 | Back to overview list |
|
CAMBRIDGE, Mass., May 24, 2022 /PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and autoimmune diseases, today announced that it will participate in the following investor conferences during June 2022:
About Myeloid Therapeutics Investor and Media Contact
View original content to download multimedia:https://www.prnewswire.com/news-releases/myeloid-therapeutics-to-participate-at-investor-conferences-in-june-2022-301554354.html SOURCE Myeloid Therapeutics |
||
|
||
Copyright 2022 PR Newswire Association LLC. | Back to overview list |